Cargando…

Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis

INTRODUCTION: Vasculopathy, inflammatory fibrosis and functional autoantibodies (Abs) are major manifestations of systemic sclerosis (SSc). Abs directed against the angiotensin II type 1 receptor (AT(1)R) and endothelin-1 type A receptor (ET(A)R) are associated with characteristic disease features i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kill, Angela, Tabeling, Christoph, Undeutsch, Reinmar, Kühl, Anja A, Günther, Jeannine, Radic, Mislav, Becker, Mike O, Heidecke, Harald, Worm, Margitta, Witzenrath, Martin, Burmester, Gerd-Rüdiger, Dragun, Duska, Riemekasten, Gabriela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978438/ https://www.ncbi.nlm.nih.gov/pubmed/24472528 http://dx.doi.org/10.1186/ar4457

Ejemplares similares

Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients
por: Günther, Jeannine, et al.
Publicado: (2014)

Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension
por: Tabeling, Christoph, et al.
Publicado: (2022)

Comprehensive autoantibody profiles in systemic sclerosis: Clinical cluster analysis
por: Höppner, Jakob, et al.
Publicado: (2023)

Autoantibodies Targeting AT(1)- and ET(A)-Receptors Link Endothelial Proliferation and Coagulation via Ets-1 Transcription Factor
por: Catar, Rusan, et al.
Publicado: (2021)

Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis
por: Weigold, Florian, et al.
Publicado: (2018)

The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers
por: Kopetschke, Katharina, et al.
Publicado: (2015)

Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study
por: Brueckner, Claudia S, et al.
Publicado: (2010)

CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice
por: Weigert, Olivia, et al.
Publicado: (2013)

Regulatory T cells inhibit autoantigen-specific CD4(+) T cell responses in lupus-prone NZB/W F1 mice
por: Rosenberger, Stefan, et al.
Publicado: (2023)

IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS
por: Hartwig, Jelka, et al.
Publicado: (2020)

Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis
por: Hegner, Björn, et al.
Publicado: (2016)

Type 1 regulatory T cells in treatment of murine lupus
por: Undeutsch, R, et al.
Publicado: (2005)

Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
por: Graßhoff, Hanna, et al.
Publicado: (2022)

Cytokine imbalance in NZB/W mice is associated with autoantibody levels and nephritis
por: Enghard, P, et al.
Publicado: (2004)

Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-α signaling
por: Moll, Guido, et al.
Publicado: (2023)

Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3
por: Recke, Andreas, et al.
Publicado: (2018)

Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation
por: Philippe, Aurélie, et al.
Publicado: (2022)

Disturbed microcirculation in the hands of patients with systemic sclerosis detected by fluorescence optical imaging: a pilot study
por: Friedrich, Stefanie, et al.
Publicado: (2017)

Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features
por: Mierau, Rudolf, et al.
Publicado: (2011)

Is Th17-Targeted Therapy Effective in Systemic Lupus Erythematosus?
por: Petrić, Marin, et al.
Publicado: (2023)

Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients
por: Hanke, Katharina, et al.
Publicado: (2009)

Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/- Mice
por: Yue, Xiaoyang, et al.
Publicado: (2021)

GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis
por: Cabral-Marques, Otavio, et al.
Publicado: (2018)

Specific Autoantibodies in Neovascular Age-Related Macular Degeneration: Evaluation of Morphological and Functional Progression over Five Years
por: Prasuhn, Michelle, et al.
Publicado: (2021)

Autoantibodies directed against α1-adrenergic receptor and endothelin receptor A in patients with prostate cancer
por: Wallukat, Gerd, et al.
Publicado: (2020)

IL-2 Therapy Diminishes Renal Inflammation and the Activity of Kidney-Infiltrating CD4+ T Cells in Murine Lupus Nephritis
por: Rose, Angelika, et al.
Publicado: (2019)

Renin‐Angiotensin and Endothelin Systems in Patients Post‐Takotsubo Cardiomyopathy
por: Khan, Hilal, et al.
Publicado: (2022)

Endothelin-1 in systemic sclerosis
por: Aghaei, Mehrdad, et al.
Publicado: (2012)

Predictive and Prognostic Value of sPRR in Patients with Primary Epithelial Ovarian Cancer
por: Kreienbring, Katrin, et al.
Publicado: (2016)

Autoantibodies from Patients with Scleroderma Renal Crisis Promote PAR-1 Receptor Activation and IL-6 Production in Endothelial Cells
por: Simon, Michèle, et al.
Publicado: (2021)

When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis
por: Akbarzadeh, Reza, et al.
Publicado: (2023)

Pulmonary Ultrasonography in Systemic Sclerosis-Induced Interstitial Lung Disease—A Systematic Review and Meta-Analysis
por: Radić, Mislav, et al.
Publicado: (2023)

Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice
por: Klocke, Jan, et al.
Publicado: (2019)

What Makes Antibodies Against G Protein-Coupled Receptors so Special? A Novel Concept to Understand Chronic Diseases
por: Riemekasten, Gabriela, et al.
Publicado: (2020)

Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Freitag, Helma, et al.
Publicado: (2021)

Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus
por: Henneken, Maren, et al.
Publicado: (2005)

Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay
por: Egerer, Karl, et al.
Publicado: (2011)

The first composite score predicting Digital Ulcers in systemic sclerosis patients using Clinical data, Imaging and Patient history—CIP-DUS
por: Friedrich, S., et al.
Publicado: (2020)

Endothelin System and Ischemia-Induced Ventricular Tachyarrhythmias
por: Mouchtouri, Eleni-Taxiarchia, et al.
Publicado: (2022)

Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests
por: Egerer, Karl, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8lejp8cvbj7blf01up6k25v5jm